Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.

TERN · Nasdaq

Terns Pharmaceuticals, Inc. (TERN) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Terns Pharmaceuticals, Inc. in 2026.

Earnings calendar

Next earnings date

—

Not scheduled

EPS estimate

—

Revenue estimate

—

Past earnings

18 May 2026
EPS actual
—
estimate -0.26
Revenue actual
—
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
10 Nov 2025
EPS actual
-0.27 (+8.3%)
estimate -0.29
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase Ib clinical trial for the treatment of NASH. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase I clinical trial for the treatment of NASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for NASH and metabolic diseases, such as obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Amy L. Burroughs
Employees
59
IPO date
05 Feb 2021
ISIN
US8808811074
Website
ternspharma.com

Frequently asked questions

What was Terns Pharmaceuticals, Inc.'s most recent earnings date?

Terns Pharmaceuticals, Inc. (TERN) last reported earnings on May 18, 2026.

Where is Terns Pharmaceuticals, Inc. stock listed?

Terns Pharmaceuticals, Inc. (TERN) is listed on Nasdaq.